MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Minimal impact of “interleaving” on neuromodulation device battery drain when interleave frequency is halved

Y.M. Fernandez, D.L. Caputo, D.P. Schneider, S.F. Danish, R.J. Dipaola, E.L. Hargreaves (New Brunswick, NJ, USA)

Meeting: 2016 International Congress

Abstract Number: 46

Keywords: Deep brain stimulation (DBS), Essential tremor(ET), Neurostimulation, Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Surgical therapy: Parkinson's disease

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To contrast neurostimulator battery decay subsequent to the implementation of interleaving with that prior to interleaving.

Background: Neurostimulators permit “interleaving”, which allows different same-lead contacts to alternate between emitting pulses during Deep Brain Stimulation (DBS). DBS patients programmed with interleave configurations have been found to have less side effects (Ramirez-Zamora et al., 2014). Further, we demonstrated in a small Essential Tremor (ET) DBS case series that the Total Electrical Energy Delivered (TEED) interleave estimates were less than their immediate non-interleave equivalents, if the interleave frequency were halved, suggesting less battery drain (Feinstein, et al., 2015). Here, we provide clinical support for this claim by comparing battery drain, subsequent- and prior- to DBS interleaving.

Methods: We conducted a retrospective chart review of 54 patients managed in our practice who were implanted with Activa PCs for Movement Disorders, in any of the Ventral Intermediate nucleus of the Thalamus (VIM), the Globus Pallidus interna (GPi), and the subthalamic nucleus (STN) targets. All battery charge estimates prior- and subsequent- to interleave implementation had to fall within the linear portion of the overall decay curve, being less than 2.99V and greater than 2.82V (Montuno et al., 2013; Patel et al., 2015). Of the 54 charts reviewed 18 met the criteria.

Results: An average of 369 days (sem=52.3) across 4.4 visits were analyzed prior to interleave implementation, while an average of 335 days (sem=34.5) across 4.9 visits were analyzed subsequent to interleaving. The slopes of linear regressions fit to each individual’s prior- and subsequent- interleave decay curves were analyzed with paired t-tests. Overall, no differences were found between the decay slopes [t(17)=0.64; p=0.52]. However, consistent with our previous work, when the 7 cases with no substantial drop in frequency (halving) during the interleave implementation were removed, then statistically significant differences were revealed, favoring the interleaves with lessened decay slopes [t(10)=2.44; p=0.035].

Conclusions: Interleaving does not result in greater battery drain. Further, interleaving does result in lessened battery decay, when the frequency is halved during implementation.

To cite this abstract in AMA style:

Y.M. Fernandez, D.L. Caputo, D.P. Schneider, S.F. Danish, R.J. Dipaola, E.L. Hargreaves. Minimal impact of “interleaving” on neuromodulation device battery drain when interleave frequency is halved [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/minimal-impact-of-interleaving-on-neuromodulation-device-battery-drain-when-interleave-frequency-is-halved/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/minimal-impact-of-interleaving-on-neuromodulation-device-battery-drain-when-interleave-frequency-is-halved/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley